Recombinant programmed cell death protein 1 functions as an immune check point blockade and enhances anti-cancer immunity
J Hwang, EK An, W Zhang, HB Park, SJ Kim, D Yadav… - Biomaterials, 2022 - Elsevier
Effective cancer therapy aims to treat not only primary tumors but also metastatic and
recurrent cancer. Immune check point blockade-mediated immunotherapy showed …
recurrent cancer. Immune check point blockade-mediated immunotherapy showed …
[PDF][PDF] Recombinant programmed cell death protein 1 functions as an immune check point blockade and enhances anti-cancer immunity
J Hwang, EK An, W Zhang, HB Park, SJ Kim… - …, 2022 - drive.google.com
Effective cancer therapy aims to treat not only primary tumors but also metastatic and
recurrent cancer. Immune check point blockade-mediated immunotherapy showed …
recurrent cancer. Immune check point blockade-mediated immunotherapy showed …
Recombinant programmed cell death protein 1 functions as an immune check point blockade and enhances anti-cancer immunity
J Hwang, EK An, W Zhang, HB Park, SJ Kim… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Effective cancer therapy aims to treat not only primary tumors but also metastatic and
recurrent cancer. Immune check point blockade-mediated immunotherapy showed …
recurrent cancer. Immune check point blockade-mediated immunotherapy showed …
Recombinant programmed cell death protein 1 functions as an immune check point blockade and enhances anti-cancer immunity.
J Hwang, EK An, W Zhang, HB Park, SJ Kim, D Yadav… - Biomaterials, 2022 - europepmc.org
Effective cancer therapy aims to treat not only primary tumors but also metastatic and
recurrent cancer. Immune check point blockade-mediated immunotherapy showed …
recurrent cancer. Immune check point blockade-mediated immunotherapy showed …